跳至主要内容
临床试验/NCT07279844
NCT07279844尚未招募不适用

An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

Anhui Provincial Hospital0 个研究点目标入组 6 人开始时间: 2025年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
6
主要终点
To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

研究概览

简要总结

To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

详细描述

An open-label, observational, long-term follow-up study evaluating the safety and efficacy of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who have previously participated in RGL-193-related studies and have received RGL-193 treatment;
  • Those who voluntarily participate in this trial and sign a written informed consent form -

排除标准

  • 未提供

结局指标

主要结局

To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

时间窗: 52 weeks after core-shell injection

次要结局

  • Assess the metabolic activity of related enzymes in patients with primary PD over 5 years following RGL-193 capsid injection.(52 weeks after core-shell injection)

研究者

发起方
Anhui Provincial Hospital
申办方类型
Other Gov
责任方
Sponsor

相似试验